PLOS: A Global Biomedical R&D Fund and Mechanism for Innovations of Public Health Importance

Manica Balasegaram, Christian Bréchot, Jeremy Farrar, David Heymann, Nirmal Ganguly, Martin Khor, Yves Lévy, Precious Matsoso, Ren Minghui, Bernard Pécoul , Liu Peilong, Marcel Tanner, John-Arne Røttingen

Read the complete article at PLOS: Medicine

Summary Points

  • Anti-microbial resistance, emerging infectious diseases, and
    neglected diseases are all important public health concerns and
    priorities with serious market failures, deficits, and identified needs
    in biomedical innovation.
  • It is important to reconcile, rather than fragment, the needs of
    these three priority areas by considering an umbrella framework for
    specifically financing and coordinating research and development
    (R&D) that delivers innovation while securing patient access.
  • A sizeable, sustainably financed global R&D fund and mechanism
    that promotes coordination, collaboration, and utilization of new and
    innovative incentives should be set up to cover all three priority
    areas.

Read the complete article at PLOS: Medicine